Adding a PD-1 inhibitor to standard of care improved disease-free survival (DFS) in stage III soft-tissue sarcoma of the ...

Patients with bone and soft tissue sarcomas are treated in the Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center by a multidisciplinary team of cancer experts. Orthopedic ...

There are around 100 different subtypes of sarcoma that can be classified into three broad groups: soft tissue sarcoma; primary bone sarcoma; and gastro-intestinal stromal tumours.

Synovial sarcomas arise in muscle and connective tissue and account for approximately 5% to 10% of all soft tissue sarcomas ... and the five-year survival rate for patients diagnosed at an ...

Intensity Therapeutics, Inc. ("Intensity" or the "Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...

The SU2C-SARC032 study demonstrated that pembrolizumab combined with radiotherapy and surgery was well tolerated, with ...

Therefore, a new corpus sarcoma staging system was developed based on the criteria used in other soft tissue sarcomas. [2] This is described as a best guess staging system, so data will need to be ...

GeneTether Therapeutics Inc. (CSE: GTTX) today announced that it has changed its name to Rize Oncology Inc. (“Rize” or the “Company”). This rebranding reflects the Company's strategic shift towards ...